Corrigendum to Melatonin reduces excitotoxic blood-brain barrier breakdown in neonatal rats [Neuroscience, 311, (2015), 382-397] DOI: 10.1016/j.neuroscience.2015.10.044;Melatonin reduces excitotoxic blood-brain barrier breakdown in neonatal rats

Neuroscience

Volumn 311, Issue , 2015, Pages 382-397

  Moretti, R ^a,b,c,d,e   Zanin, A ^b,c,d   Pansiot, J ^b,c,d   Spiri, D ^b,c,d   Manganozzi, L ^b,c,d   Kratzer, I ^f   Favero, G ^g   Vasiljevic, A ^f   Rinaldi, V E ^b,c,d   Pic, I ^b,c,d   Massano, D ^b,c,d   D'Agostino, I ^b,c,d   Baburamani, A ^h   La Rocca, M A ^b,c,d   Rodella, L F ^g   Rezzani, R ^g   Ek, J ^h   Strazielle, N ^f,i   Ghersi Egea, J F ^f   Gressens, P ^b,c,d,j   Titomanlio, L ^a,b,c,d   more..

^a HÔPITAL ROBERT DEBRÉ   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d PremUP   (France)

^e UNIVERSITY OF UDINE   (Italy)

^f LYON NEUROSCIENCE RESEARCH CENTER   (France)

^g UNIVERSITY OF BRESCIA   (Italy)

^h UNIVERSITY OF GOTHENBURG   (Sweden)

ⁱ Brain i   (France)

^j ST THOMAS HOSPITAL   (United Kingdom)

more..

Author keywords

Blood brain barrier; Brain development; Ibotenate; Melatonin; Periventricular white matter damage

Indexed keywords

DEXTRAN; IBOTENIC ACID; MELATONIN; PHOSPHATE BUFFERED SALINE; TIGHT JUNCTION PROTEIN; AMINO ACID RECEPTOR AFFECTING AGENT; GLUTAMIC ACID; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CORTEX; BRAIN DAMAGE; CHOROID PLEXUS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EXTRAVASATION; EXCITOTOXICITY; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; NEUROPROTECTION; NEUROTOXICITY; NEWBORN; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; WHITE MATTER; ANALOGS AND DERIVATIVES; ANIMAL; CAPILLARY PERMEABILITY; DISEASE MODEL; DRUG EFFECTS; METABOLISM; PATHOLOGY; PHYSIOLOGY; RANDOMIZATION; SPRAGUE DAWLEY RAT;

ANIMALS; ANIMALS, NEWBORN; BLOOD-BRAIN BARRIER; CAPILLARY PERMEABILITY; DISEASE MODELS, ANIMAL; EXCITATORY AMINO ACID AGENTS; GENE EXPRESSION; GLUTAMIC ACID; IMMUNOHISTOCHEMISTRY; MELATONIN; NEUROPROTECTIVE AGENTS; RANDOM ALLOCATION; RATS, SPRAGUE-DAWLEY;

EID: 84946573977     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2015.11.014     Document Type: Erratum

References (58)

1. Abbott N.J., et al. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006, 7:41-53.
2. Abbott N.J., et al. Structure and function of the blood-brain barrier. Neurobiol Dis 2010, 37:13-25.
3. Bazzoni G., et al. Interaction of junctional adhesion molecule with the tight junction components ZO-1, cingulin, and occludin. J Biol Chem 2000, 275:20520-20526.
4. Bouslama M., et al. Treatment-induced prevention of learning deficits in newborn mice with brain lesions. Neuroscience 2006, 141:795-801.
5. Chen J., et al. Melatonin attenuates inflammatory response-induced brain edema in early brain injury following a subarachnoid hemorrhage: a possible role for the regulation of pro-inflammatory cytokines. J Pineal Res 2014, 57:340-347.
6. Dammann O., Leviton A. Inflammatory brain damage in preterm newborns-dry numbers, wet lab, and causal inferences. Early Hum Dev 2004, 79:1-15.
7. Dehghan F., et al. Effect of melatonin on intracranial pressure and brain edema following traumatic brain injury: role of oxidative stresses. Arch Med Res 2013, 44:251-258.
8. Dommergues M.A., et al. Proinflammatory cytokines and interleukin-9 exacerbate excitotoxic lesions of the newborn murine neopallium. Ann Neurol 2000, 47:54-63.
9. Ek C.J., et al. Permeability and route of entry for lipid-insoluble molecules across brain barriers in developing Monodelphis domestica. J Physiol 2001, 536:841-853.
10. Ek C.J., et al. Functional effectiveness of the blood-brain barrier to small water-soluble molecules in developing and adult opossum (Monodelphis domestica). J Comp Neurol 2006, 496:13-26.
11. Ek C.J., et al. Barriers in the developing brain and Neurotoxicology. Neurotoxicology 2012, 33:586-604.
12. Ek C.J., et al. Brain barrier properties and cerebral blood flow in neonatal mice exposed to cerebral hypoxia-ischemia. J Cereb Blood Flow Metab 2015.
13. Fernandez-Lopez D., et al. Blood-brain barrier permeability is increased after acute adult stroke but not neonatal stroke in the rat. J Neurosci 2012, 32:9588-9600.
14. Forster C. Tight junctions and the modulation of barrier function in disease. Histochem Cell Biol 2008, 130:55-70.
15. Fulia F., et al. Increased levels of malondialdehyde and nitrite/nitrate in the blood of asphyxiated newborns: reduction by melatonin. J Pineal Res 2001, 31:343-349.
16. Galano A., et al. On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK. J Pineal Res 2013, 54:245-257.
17. Gitto E., et al. Effects of melatonin treatment in septic newborns. Pediatr Res 2001, 50:756-760.
18. Gitto E., et al. Protective role of melatonin in neonatal diseases. Oxid Med Cell Longev 2013, 2013:980374.
19. Gressens P., et al. Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain. J Clin Invest 1997, 100:390-397.
20. Gressens P., et al. The effects of AMPA receptor antagonists in models of stroke and neurodegeneration. Eur J Pharmacol 2005, 519:58-67.
21. Habgood M.D., et al. The nature of the decrease in blood-cerebrospinal fluid barrier exchange during postnatal brain development in the rat. J Physiol 1993, 468:73-83.
22. Hardeland R., et al. Melatonin, the circadian multioscillator system and health: the need for detailed analyses of peripheral melatonin signaling. J Pineal Res 2012, 52:139-166.
23. Husson I., et al. Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge. Ann Neurol 2002, 51:82-92.
24. Husson I., et al. BDNF-induced white matter neuroprotection and stage-dependent neuronal survival following a neonatal excitotoxic challenge. Cereb Cortex 2005, 15:250-261.
25. Johansson P.A., et al. The blood-CSF barrier explained: when development is not immaturity. BioEssays 2008, 30:237-248.
26. Johnston M.V. Excitotoxicity in perinatal brain injury. Brain Pathol 2005, 15:234-240.
27. Kabadi S.V., Maher T.J. Posttreatment with uridine and melatonin following traumatic brain injury reduces edema in various brain regions in rats. Ann N Y Acad Sci 2010, 1199:105-113.
28. Kaur C., Ling E.A. Blood brain barrier in hypoxic-ischemic conditions. Curr Neurovasc Res 2008, 5:71-81.
29. Kaur C., et al. Melatonin attenuates hypoxia-induced ultrastructural changes and increased vascular permeability in the developing hippocampus. Brain Pathol 2008, 18:533-547.
30. Kratzer I., et al. Complexity and developmental changes in the expression pattern of claudins at the blood-CSF barrier. Histochem Cell Biol 2012, 138:861-879.
31. Kratzer I., et al. Developmental changes in the transcriptome of the rat choroid plexus in relation to neuroprotection. Fluids Barriers CNS 2013, 10:25.
32. Laudenbach V., et al. Nociceptin/orphanin FQ exacerbates excitotoxic white-matter lesions in the murine neonatal brain. J Clin Invest 2001, 107:457-466.
33. Li Y.N., et al. Ischemic neurons activate astrocytes to disrupt endothelial barrier via increasing VEGF expression. J Neurochem 2014, 129:120-129.
34. Liddelow S.A., et al. Mechanisms that determine the internal environment of the developing brain: a transcriptomic, functional and ultrastructural approach. PLoS One 2013, 8:e65629.
35. Marchiando A.M., et al. Caveolin-1-dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo. J Cell Biol 2010, 189:111-126.
36. Marret S., et al. Effect of ibotenate on brain development: an excitotoxic mouse model of microgyria and posthypoxic-like lesions. J Neuropathol Exp Neurol 1995, 54:358-370.
37. Murakami T., et al. Occludin phosphorylation and ubiquitination regulate tight junction trafficking and vascular endothelial growth factor-induced permeability. J Biol Chem 2009, 284:21036-21046.
38. Neuwelt E.A. Mechanisms of disease: the blood-brain barrier. Neurosurgery 2004, 54:131-140. discussion 141-142.
39. Neuwelt E., et al. Strategies to advance translational research into brain barriers. Lancet Neurol 2008, 7:84-96.
40. Nitta T., et al. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 2003, 161:653-660.
41. Northington F.J. Brief update on animal models of hypoxic-ischemic encephalopathy and neonatal stroke. ILAR J 2006, 47:32-38.
42. Pansiot J., et al. Neuroprotective effect of inhaled nitric oxide on excitotoxic-induced brain damage in neonatal rat. PLoS One 2010, 5:e10916.
43. Pei Z., et al. Melatonin reduces nitric oxide level during ischemia but not blood-brain barrier breakdown during reperfusion in a rat middle cerebral artery occlusion stroke model. J Pineal Res 2003, 34:110-118.
44. Reiter R.J., et al. Delivery of pineal melatonin to the brain and SCN: role of canaliculi, cerebrospinal fluid, tanycytes and Virchow-Robin perivascular spaces. Brain Struct Funct 2014, 219:1873-1887.
45. Sandoval K.E., Witt K.A. Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol Dis 2008, 32:200-219.
46. Saunders N.R., et al. Barriers in the brain: a renaissance?. Trends Neurosci 2008, 31:279-286.
47. Strazielle N., Ghersi-Egea J.F. Physiology of blood-brain interfaces in relation to brain disposition of small compounds and macromolecules. Mol Pharm 2013, 10:1473-1491.
48. Sundstrom J.M., et al. Identification and analysis of occludin phosphosites: a combined mass spectrometry and bioinformatics approach. J Proteome Res 2009, 8:808-817.
49. Tahraoui S.L., et al. Central role of microglia in neonatal excitotoxic lesions of the murine periventricular white matter. Brain Pathol 2001, 11:56-71.
50. Tai S.H., et al. Melatonin inhibits postischemic matrix metalloproteinase-9 (MMP-9) activation via dual modulation of plasminogen/plasmin system and endogenous MMP inhibitor in mice subjected to transient focal cerebral ischemia. J Pineal Res 2010, 49:332-341.
51. Turgut M., et al. Melatonin ameliorates blood-brain barrier permeability, glutathione, and nitric oxide levels in the choroid plexus of the infantile rats with kaolin-induced hydrocephalus. Brain Res 2007, 1175:117-125.
52. Tutunculer F., et al. The protective role of melatonin in experimental hypoxic brain damage. Pediatr Int 2005, 47:434-439.
53. Van Itallie C.M., et al. Occludin is required for cytokine-induced regulation of tight junction barriers. J Cell Sci 2010, 123:2844-2852.
54. Villapol S., et al. Melatonin promotes myelination by decreasing white matter inflammation after neonatal stroke. Pediatr Res 2011, 69:51-55.
55. Weiss M.D., et al. Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia. J Am Acad Child Adolesc Psychiatry 2006, 45:512-519.
56. Witt K.A., et al. Reoxygenation stress on blood-brain barrier paracellular permeability and edema in the rat. Microvasc Res 2008, 75:91-96.
57. Yon J.H., et al. Melatonin reduces the severity of anesthesia-induced apoptotic neurodegeneration in the developing rat brain. Neurobiol Dis 2006, 21:522-530.
58. Zhang H.M., Zhang Y. Melatonin: a well-documented antioxidant with conditional pro-oxidant actions. J Pineal Res 2014, 57:131-146.